[go: up one dir, main page]

KR102132514B1 - A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium - Google Patents

A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium Download PDF

Info

Publication number
KR102132514B1
KR102132514B1 KR1020170083419A KR20170083419A KR102132514B1 KR 102132514 B1 KR102132514 B1 KR 102132514B1 KR 1020170083419 A KR1020170083419 A KR 1020170083419A KR 20170083419 A KR20170083419 A KR 20170083419A KR 102132514 B1 KR102132514 B1 KR 102132514B1
Authority
KR
South Korea
Prior art keywords
hot water
ethyl acetate
water extract
cucumber
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020170083419A
Other languages
Korean (ko)
Other versions
KR20190003009A (en
Inventor
최창원
오성
김성대
노한별
Original Assignee
배재대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 배재대학교 산학협력단 filed Critical 배재대학교 산학협력단
Priority to KR1020170083419A priority Critical patent/KR102132514B1/en
Publication of KR20190003009A publication Critical patent/KR20190003009A/en
Application granted granted Critical
Publication of KR102132514B1 publication Critical patent/KR102132514B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 오이풀(Sanguisorba officinalis L.)의 뿌리(지유) 부분를 열수(hot water)로 추출한 후 추출물 및 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 화장료 조성물이다. The present invention extracts the root (oil) portion of cucumber grass (Sanguisorba officinalis L.) having specific antimicrobial activity of Propionibacterium acnes with hot water, and extracts and ethyl acetate fractions thereof It is a cosmetic composition comprising a.

Description

여드름 원인 세균에 대한 특이적 항균 활성을 가지는 오이풀 열수추출물 또는 이의 분획물을 포함하는 화장료 조성물{A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium}A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium}

본 발명은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 오이풀(Sanguisorba officinalis L.)의 뿌리(지유) 부분을 열수(hot water)로 추출한 후 추출물 또는 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 화장료 조성물에 관한 것이다. The present invention extracts the root (oil) part of cucumber (Sanguisorba officinalis L.) having specific antimicrobial activity of propionibacterium acnes with hot water and extracts or ethyl acetate thereof It relates to a cosmetic composition comprising a fraction.

여드름(Acne vulgaris)은 피부의 탈피지 샘 단위(pilosebaceous unit)에 가장 흔하게 발생하는 염증성 질환으로서, 특히 사춘기 남성의 얼굴에 가장 흔하게 발생하고 간혹 등, 가슴 혹은 어깨에도 나타난다. 주원인은 피지선의 확장 및 면포(comedone) 형성과 함께 지나친 피지 (sebum)의 생산을 유도하는 남성호르몬 (androgen)의 효과에 기인한다. 다른 주원인은 비정상적 모낭 상피의 박리(피부 각질) 및 프로피오니박테리움 애크니스의 증식 때문이다. Acne vulgaris is the most common inflammatory disease in the skin's pilosebaceous unit, most commonly on the face of adolescent men and occasionally on the chest, shoulders, etc. The main cause is due to the effect of the male hormone (androgen) which induces excessive sebum production along with the expansion of the sebaceous glands and formation of comedone. The other main causes are due to abnormal detachment of the hair follicle epithelium (skin keratin) and proliferation of propionium bacterium acne.

프로피오니박테리움 애크니스는 탈피지샘 단위에서 공생균으로 살아가는 혐기성(anaerobic), 그람양성(Gram positive), 간균(bacillus)이다. 비정상적 모낭 상피의 박리는 모낭에서 혐기성 조건을 일으켜 프로피오니박테리움 애크니스의 증식을 촉진한다. 또한, 프로피오니박테리움 애크니스는 지방분해효소(lipase) 및 주화성 인자를 분비하여 지나치게 분비된 피지 트리글리세리드(triglyceride)의 글리세롤 성분을 유리 지방산(free fatty acids)으로 물질대사 시킨다. 이러한 여분의 유리 지방산은 모낭 주위에 염증성 백혈구 생성을 촉진시킨다. 반면에 프로피오니박테리움 애크니스의 증식을 억제하면 면포의 파열을 최소화하여 여드름의 발달을 억제할 수 있다.Propionibacterium acnes are anaerobic, gram positive, and bacillus that live as symbiotic bacteria in the sebaceous gland unit. Abnormal peeling of the hair follicle epithelium creates anaerobic conditions in the hair follicle, thereby promoting the propagation of propionibacterium acnes. In addition, propionibacterium acne secretes lipolytic enzymes and chemotactic factors to metabolize excessively secreted glycerol components of sebum triglyceride into free fatty acids. These extra free fatty acids promote the production of inflammatory white blood cells around the hair follicles. On the other hand, inhibiting the growth of propionibacterium acne can minimize the rupture of cotton and suppress the development of acne.

여드름 치료에 테트라사이클린(tetracycline), 에리쓰로마이신(erythromycin) 및 클린다마이신(clindamycin)과 같은 여러 가지 경구용 혹은 경피용 항생제가 사용되어 왔다. 이러한 광범위 스펙트럼을 가진 항생제의 장기간 사용은 캔디다 알비칸스(Candida albicans)의 과대성장 및 항생제 내성을 일으킬 수 있다. 또한, 항여드름 치료제로 알려진 과산화벤조일(benzoyl peroxide), 아젤라산(azelaic acid) 및 레티노산(retinoic acid)과 같은 경피용 화학제는 피부자극 및 접촉성피부염과 같은 부작용을 갖는 문제점이 있다. Various oral or transdermal antibiotics such as tetracycline, erythromycin and clindamycin have been used to treat acne. Long-term use of antibiotics with this broad spectrum can cause overgrowth of Candida albicans and antibiotic resistance. In addition, transdermal chemicals such as benzoyl peroxide, azelaic acid, and retinoic acid, which are known as anti-acne treatments, have a side effect such as skin irritation and contact dermatitis.

상기와 같은 문제점을 해결하기 위해 최근에 국제적으로 많은 항균성 식물이 보고되어 왔다. 그중에 일부는 여드름 치료에 대체 약물로 활용될 수 있다. 식물을 포함하여 현재 보고된 단일 식물의 표적 조직으로부터 획득한 추출물에서 프로피오니박테리움 애크니스에 대해 뚜렷한 항균활성을 나타낸 대다수의 추출물은 메탄올(특허문헌 0001, 0002, 0003 및 비특허문헌 0001, 0002, 0003, 0004), 에탄올(특허문헌 0004, 0005, 0006, 0007, 0008 및 비특허문헌 0005, 0006, 0007, 0008, 0009, 0010, 0011), 열수(특허문헌0009, 0010 및 비특허문헌 0012), 인산완충용액(특허문헌 0011), 아세톤(비특허문헌 0013), 기타 유기용매(비특허문헌 0014, 0015) 및 수증기증류법(특허문헌 0012 및 비특허문헌 0016)를 이용하였다. In order to solve the above problems, many antibacterial plants have been recently reported internationally. Some of them can be used as a substitute for acne treatment. The majority of extracts showing distinct antimicrobial activity against propionium bacterium acne in extracts obtained from target tissues of a single plant, including plants, currently reported are methanol (Patent Documents 0001, 0002, 0003 and Non-Patent Documents 0001, 0002 , 0003, 0004), ethanol (patent documents 0004, 0005, 0006, 0007, 0008 and non-patent documents 0005, 0006, 0007, 0008, 0009, 0010, 0011), hot water (patent documents 0009, 0010 and non-patent documents 0012 ), phosphate buffer solution (patent document 0011), acetone (non-patent document 0013), other organic solvents (non-patent documents 0014, 0015) and water vapor distillation method (patent documents 0012 and non-patent documents 0016) were used.

‘할랄(Halal)’ 시장은 국제시장 규모 중 가장 큰 시장 또한 성장하는 시장으로 주목받는 시장으로서, 무슬림들의 생활 수칙이며 이를 영위하기 위하여 필요한 상품이 할랄 시장이다. 화장품의 경우 할랄 기준을 충족시키기 위해서는 식물체에서 유효 성분을 추출, 농축시키기 위하여 광범위하게 사용하는 에탄올(ethanol)을 전혀 사용할 수 없고 다가 알코올류 역시 동물 유래의 성분은 사용할 수 없다. The “Halal” market is a market that attracts attention as one of the largest in the international market, and it is also a growing market for Muslims. In the case of cosmetics, ethanol, which is widely used for extracting and concentrating active ingredients from plants, cannot be used at all to satisfy halal standards, and polyhydric alcohols cannot be used for animal-derived ingredients.

또한 발효 과정에서 사용하는 균주 역시 까다로운 기준에 따라 선택해서 사용해야 하며 발효 과정에서 생성되는 에탄올 역시 장애 요인이 될 수 있다. 따라서 다른 추출법과 비교하여 쉽게 유효성분을 추출할 수 있는 장점이 있는 열수 및 열수를 이용한 추출방식이 유일한 대안이다. In addition, strains used in the fermentation process should also be selected and used according to demanding standards, and ethanol produced during the fermentation process may also be a barrier. Therefore, compared with other extraction methods, the extraction method using hot water and hot water, which has the advantage of easily extracting the active ingredient, is the only alternative.

장미과(Rosacease)에 속한 다년생 식물인 오이풀(S. officinalis L.)은 국내를 포함한 극동 아시아 지역에 널리 분포하고 있다. 오이풀의 뿌리는 한방에서 지유(地楡)라는 생약재로 사용되고 있다(비특허문헌 0017). Cucumber (S. officinalis L.), a perennial plant belonging to the family Rosacease, is widely distributed in the Far East, including in Korea. The root of cucumber grass is used in herbal medicine as a herbal medicine (地楡) (non-patent document 0017).

지유는 한방에서 주로 지혈과 상처부위의 치료에 사용되어왔으며, 피부염, 점막염, 습진, 화상에 외용하는 것으로 알려져 있다(비특허문헌 0018). 지유에는 ziguglycoside I, II와 pomolic acid등이 함유되어 있고, 가지에는 quercetin과 kaempferol의 배당체와 ursolic acid 등 triterpenoid계 saponin 이 함유되어 있으며, 잎에는 vitamin C, 꽃에는 chrysanthemin, cyanin 등의 약리성분이 함유되어 있다 (비특허문헌 0019). Oil has been mainly used in the treatment of hemostasis and wounds in oriental medicine, and is known to be used externally for dermatitis, mucositis, eczema, and burns (non-patent document 0018). Oil contains ziguglycoside I, II, and pomolic acid. Branches contain quercetin and kaempferol glycosides, and triterpenoid-based saponins such as ursolic acid. Vitamin C on leaves, and chrysanthemin and cyanin on flowers. (Non-Patent Document 0019).

상기와 같은 약리성분에 근거하여 오이풀로부터 면역억제 활성, 항돌연변이효과, 신경세포 손상 억제효과, 항산화효과, 과민성 알레르기 예방, 항암, 항균효과, 지혈작용 등의 연구가 보고되어 왔다(비특허문헌 0017, 0020, 0021, 0022; 0023, 0024, 0025, 0026, 0027). Studies on immunosuppressive activity, antimutagenic effect, nerve cell damage suppression effect, antioxidant effect, prevention of hypersensitivity allergy, anti-cancer, antibacterial effect, and hemostatic action have been reported from cucumber grass based on the above pharmacological components (non-patent document 0017) , 0020, 0021, 0022; 0023, 0024, 0025, 0026, 0027).

오이풀 추출물에 대한 특허로는 충치를 유발하는 Streptococcus mutans 억제 구강청정제 조성물(특허문헌 0013), 패혈증을 유발하는 VHSV 및 IHNV에 대한 항바이러스 활성 조성물(특허문헌 0014), 피부부호 효과 화장료 조성물(특허문헌 0015), 당뇨 예방 및 개선용 조성물(특허문헌 0016), 리스테리 또는 살모넬라 유발 패혈증 예방 및 개선용 조성물(특허문헌 0017) 등이 있다.As a patent for cucumber extract, Streptococcus mutans-inhibiting oral cleanser composition causing cavities (Patent Document 0013), antiviral active composition against VHSV and IHNV causing sepsis (Patent Document 0014), and skin care effect cosmetic composition (Patent Document) 0015), a composition for preventing and improving diabetes (Patent Document 0016), a composition for preventing and improving Listeri or Salmonella-induced sepsis (Patent Document 0017).

대한민국 공개특허공보 제10-2015-0000723호, 2015.01.05. 공개Republic of Korea Patent Publication No. 10-2015-0000723, 2015.01.05. open 대한민국 등록특허공보 제10-1507889호, 2015.04.07. 공고Republic of Korea Registered Patent Publication No. 10-1507889, 2015.04.07. Announcement 대한민국 공개특허공보 제10-2008-0044948호, 2008.05.22. 공개Republic of Korea Patent Publication No. 10-2008-0044948, 2008.05.22. open 대한민국 공개특허공보 특2002-0003313호, 2002.01.12. 공개Republic of Korea Patent Publication No. 2002-0003313, 2002.01.12. open 대한민국 공개특허공보 특2000-0019981호, 2000.04.15. 공개Republic of Korea Patent Publication No. 2000-0019981, 2000.04.15. open 대한민국 공개특허공보 제10-2012-0086123호, 2012.08.22. 공개Republic of Korea Patent Publication No. 10-2012-0086123, 2012.08.22. open 대한민국 공개특허공보 제10-2014-00992233호, 2014.08.11. 공개Republic of Korea Patent Publication No. 10-2014-00992233, 2014.08.11. open 대한민국 공개특허공보 제10-2004-0081533호, 2004.09.22. 공개Republic of Korea Patent Publication No. 10-2004-0081533, 2004.09.22. open 대한민국 공개특허공보 제10-0700911호, 2007.03.28. 공고Republic of Korea Patent Publication No. 10-0700911, 2007.03.28. Announcement 대한민국 등록특허공보 제10-0700912호, 2007.03.28. 공고Republic of Korea Registered Patent Publication No. 10-0700912, 2007.03.28. Announcement 대한민국 공개특허공보 제10-2007-0110589호, 2007.11.20. 공개Republic of Korea Patent Publication No. 10-2007-0110589, 2007.11.20. open 대한민국 공개특허공보 특2003-0016818호, 2003.03.03. 공개Republic of Korea Patent Publication No. 2003-0016818, 2003.03.03. open 대한민국 공개특허공보 제10-2013-0113018호, 2013.10.15. 공개Republic of Korea Patent Publication No. 10-2013-0113018, 2013.10.15. open 대한민국 공개특허공보 제10-2016-0150177호, 2016.12.29. 공개Republic of Korea Patent Publication No. 10-2016-0150177, 2016.12.29. open 대한민국 공개특허공보 제10-2009-0117199호, 2009.11.12. 공개Republic of Korea Patent Publication No. 10-2009-0117199, 2009.11.12. open 대한민국 공개특허공보 제10-2016-0102638호, 2016.08.31. 공개Republic of Korea Patent Publication No. 10-2016-0102638, 2016.08.31. open 대한민국 공개특허공보 제10-2017-0055104호, 2017.05.19. 공개Republic of Korea Patent Publication No. 10-2017-0055104, 2017.05.19. open

Muddathir et al., J. Woos Sci. 2013, Vol. 59, pp. 426-431 Muddathir et al., J. Woos Sci. 2013, Vol. 59, pp. 426-431 Kim et al., J. Microbial. Biotechnol. 2010, Vol. 20, pp. 82-87 Kim et al., J. Microbial. Biotechnol. 2010, Vol. 20, pp. 82-87 Lim et al., J. Microbiol. 2007, Vol. 45, pp. 473-477 Lim et al., J. Microbiol. 2007, Vol. 45, pp. 473-477 Tsai et al., Food Chem. 2010, Vol. 119, pp. 964-968 Tsai et al., Food Chem. 2010, Vol. 119, pp. 964-968 Tangje Arung et al., Biodiversitas 2017, Vol. 18, pp. 321-325 Tangje Arung et al., Biodiversitas 2017, Vol. 18, pp. 321-325 Pothitirat et al., Pharm. Biol. 2010, Vol. 48, pp. 182-186 Pothitirat et al., Pharm. Biol. 2010, Vol. 48, pp. 182-186 Sharma and Lall, S. Afr. J. Sci. 2014, Vol. 110, Aer. # 2013-0293 Sharma and Lall, S. Afr. J. Sci. 2014, Vol. 110, Aer. # 2013-0293 Sharma et al., Phytother. Res. 2011, Vol. 25, pp. 517-521 Sharma et al., Phytother. Res. 2011, Vol. 25, pp. 517-521 Chomnawang et al., Fitoterapia 2007, Vol. 78, pp. 401-408 Chomnawang et al., Fitoterapia 2007, Vol. 78, pp. 401-408 Wang et al., J. Agric. Food Chem. 2013, Vol. 61, pp. 12274-12282 Wang et al., J. Agric. Food Chem. 2013, Vol. 61, pp. 12274-12282 Kumar et al., Trop. J. Pharm. Res. 2007, Vol. 6, pp. 717-723 Kumar et al., Trop. J. Pharm. Res. 2007, Vol. 6, pp. 717-723 Sathishkumar et al., J. Photocheml. PhotoBiol., B: Biology 2010, Vol. 20, pp. 82-87 Sathishkumar et al., J. Photocheml. Photo Biol., B: Biology 2010, Vol. 20, pp. 82-87 Vijayalakshimi et al., Int. J. PharmTech Res. 2011, Vol. 3, pp. 320-327 Vijayalakshimi et al., Int. J. PharmTech Res. 2011, Vol. 3, pp. 320-327 Shah et al., J. Med. Plants Res. 2015, Vol. 9, pp. 755-763 Shah et al., J. Med. Plants Res. 2015, Vol. 9, pp. 755-763 Pothitirat et al., Med. Princ. Pracy. 2010, Vol. 19, pp. 281-286 Pothitirat et al., Med. Princ. Pracy. 2010, Vol. 19, pp. 281-286 Qidwai et al., Int. J. Pharm. Sci. Res. 2016, Vol. 7, pp. 2917-2924 Qidwai et al., Int. J. Pharm. Sci. Res. 2016, Vol. 7, pp. 2917-2924 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 244-250 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 244-250 Son et al., J. Kor. Acad. Oral Health 2015, Vol. 28, pp. 97-104 Son et al., J. Kor. Acad. Oral Health 2015, Vol. 28, pp. 97-104 Lee et al., J. Korean Soc. Food Sci. Nutr. 2005, Vol. 34, pp. 1545-1552 Lee et al., J. Korean Soc. Food Sci. Nutr. 2005, Vol. 34, pp. 1545-1552 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 131-145 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 131-145 Ban et al., Kor. J. Med. Crop Sci. 2005, Vol. 13, pp. 219-226 Ban et al., Kor. J. Med. Crop Sci. 2005, Vol. 13, pp. 219-226 Goun et al., J. Ethnopharm. 2002, Vol. 81, pp. 337-342 Goun et al., J. Ethnopharm. 2002, Vol. 81, pp. 337-342 Hwang et al., J. Physiol. Pathol. Kor. Med. 2014, Vol. 28, pp. 499-505 Hwang et al., J. Physiol. Pathol. Kor. Med. 2014, Vol. 28, pp. 499-505 Kim et al., Nat. Prod. Sci. 2002, Vol. 8, pp. 177-182 Kim et al., Nat. Prod. Sci. 2002, Vol. 8, pp. 177-182 Kim et al., Kor. J. Food Cook. Sci. 2011, Vol. 27, pp. 15-26 Kim et al., Kor. J. Food Cook. Sci. 2011, Vol. 27, pp. 15-26 Park et al., Kor. J. Herb. 2012, Vol. 27, pp. 23-29 Park et al., Kor. J. Herb. 2012, Vol. 27, pp. 23-29 Park et al., Korean J. Food Preserv. 2012, Vol. 19, pp 744-750 Park et al., Korean J. Food Preserv. 2012, Vol. 19, pp 744-750

본 발명의 목적은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 지유(오이풀의 뿌리)의 열수 추출물 또는 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 화장료 조성물을 제공하는 것이다.It is an object of the present invention to provide a cosmetic composition comprising a hydrothermal extract of oil (root of cucumber) or a ethyl acetate fraction thereof having specific antimicrobial activity of Propionibacterium acnes.

상기 목적을 달성하기 위하여, 본 발명은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 지유(오이풀의 뿌리) 열수 추출물 또는 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 여드름 예방 또는 개선용 화장료 조성물을 제공한다. In order to achieve the above object, the present invention is to prevent or improve acne containing propionibacterium acnes (Propionibacterium acnes) specific antibacterial activity oil (root of cucumber) hot water extract or its ethyl acetate fraction. Provide a cosmetic composition for.

상기에 기술한 바와 같이, 본 발명에 따르면 지유의 열수 추출물 또는 이의 분획물은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지므로, 여드름의 예방 또는 개선에 효과가 있다. 따라서 이를 이용하여 화장료 조성물, 더 자세하게는 화장료, 비누 및 세정제 조성물 등으로 제품화 할 수 있다. As described above, according to the present invention, the hydrothermal extract of oil or a fraction thereof has antibacterial activity specific to Propionibacterium acnes, and thus is effective in preventing or improving acne. Therefore, it can be commercialized as a cosmetic composition, more specifically, a cosmetic composition, a soap, and a detergent composition.

도 1은 지유의 열수추출물(HWE)로부터 활성 분획 분리과정의 흐름도이다.
도 2는 지유 열수추출물(HWE) 및 열수추출물의 에틸아세테이트 분획물(HWE-EA)의 여드름균(Propionibacterium acnes)에 대한 항균활성을 분석한 원판 평판배지 확산법(paper disc agar diffusion method)이다. 그림 (A)는 HWE 10 mg/disk 처리구(1), 무처리구(2), 증류수처리구(3)의 여드름균에 대한 억제환을 관찰한 사진이다. 그림 (B)는 증류수처리구(1) 및 HWE 1 mg/disk 처리구(2), 3 mg/disk 처리구(3), 5 mg/disk 처리구(4)의 여드름균에 대한 억제환을 관찰한 사진이다. 그림 (C)는 증류수처리구(1) 및 HWE-EA 1 mg/disk 처리구(2), 3 mg/disk 처리구(3), 5 mg/disk 처리구(4)의 여드름 균에 대한 억제환을 관찰한 사진이다.
도 3은 지유의 열수추출물(HWE)의 n-헥산(n-hexane), 에틸아세테이트(ethyl acetate), n-부탄올(n-butanol) 및 물 분획물을 원판 평판배지 확산법(paper disc agar diffusion method)에 의해 여드름균 억제를 비교 결과이다.
도 4는 지유의 열수추출물(HWE)의 여드름균(Propionibacterium acnes)에 대한 최소억제농도(MIC) 및 최소살균농도(MBC)를 확인하기 위하여 고체배지에 콜로니 형성 유무를 확인한 결과이다.
도 5는 지유의 열수추출물(HWE)의 에틸아세테이트(ethyl acetate) 분획물을 silica gel 60 glass plate에 점지하고 혼합용매 ethyl acetate, n-hexane, chloroform, acetic acid(40:30:30:2, v/v/v/v) 로 전개하고 UV 파장 254 nm (A), 366 nm (B) 및 황산 스프레이 발색법 (C)으로 분석한 것이다.
도 6은 지유의 열수추출물(HWE)의 에틸아세테이트(ethyl acetate) 분획물을 TLC에서 전개한 후 획득하여 HPLC로 분석한 것이다. (1) 분리되지 않은 혼합 화합물, (2) caffeic acid, (3) ferulic acid, (4) quercetin, (5) kaempferol 이다.
Figure 1 is a flow diagram of the active fraction separation process from the hot water extract (HWE) of the oil.
FIG. 2 is a paper disc agar diffusion method that analyzes the antibacterial activity of Propylonibacterium acnes of the oily hot water extract (HWE) and the ethyl acetate fraction (HWE-EA) of the hot water extract. Figure (A) is a photograph of the HWE 10 mg/disk treatment tool (1), no treatment tool (2), and distilled water treatment tool (3) for the inhibition of acne bacteria. Figure (B) is a picture of observing the inhibitory ring against acne bacteria in distilled water treatment (1) and HWE 1 mg/disk treatment (2), 3 mg/disk treatment (3), and 5 mg/disk treatment (4) . Figure (C) observed distilled water treatment (1) and HWE-EA 1 mg/disk treatment (2), 3 mg/disk treatment (3), and 5 mg/disk treatment (4) for the inhibition of acne bacteria It is a picture.
FIG. 3 is a paper disc agar diffusion method of n-hexane, ethyl acetate, n-butanol, and water fractions of hot water extract (HWE) of oil. It is a result of comparing the suppression of acne bacteria.
Figure 4 is a result of confirming the presence or absence of colony formation in a solid medium to determine the minimum inhibitory concentration (MIC) and the minimum sterilization concentration (MBC) for the acne (Propionibacterium acnes) of the hot water extract (HWE) of oil.
Figure 5 is the ethyl acetate (ethyl acetate) fraction of the hot water extract (HWE) of fat oil on a silica gel 60 glass plate and mixed solvent ethyl acetate, n-hexane, chloroform, acetic acid (40:30:30:2, v /v/v/v) and analyzed by UV wavelength 254 nm (A), 366 nm (B) and sulfuric acid spray coloration (C).
Figure 6 is obtained by developing the ethyl acetate (ethyl acetate) fraction of the hot water extract (HWE) of the oil in TLC and analyzed by HPLC. (1) mixed compounds that are not isolated, (2) caffeic acid, (3) ferulic acid, (4) quercetin, and (5) kaempferol.

본 발명의 일실시예는 오이풀 (Sanguisorba officinalis)의 열수추출물 또는 이의 분획물을 포함하는 여드름 개선용 화장료 조성물을 제공할 수 있다. One embodiment of the present invention can provide a cosmetic composition for improving acne comprising a hot water extract or a fraction thereof of cucumber (Sanguisorba officinalis).

오이풀은 장미과에 속하는 여러해살이풀이다. 한국, 일본, 유럽, 중국 만주 등지에 분포한다. 잎을 따서 부비면 오이냄새가 나서 오이풀이라 부른다. 한방에서는 오이풀의 뿌리를 지유라는 약재로 사용하고 있다. 오이풀 뿌리에는 17%타닌과 2.5%의 사포닌, Sanguisorbigenin이라는 배당체가 들어있고, 줄기와 잎에는 qurcetin과 Kaemferol 배당체, Ursolic acid 등 Triterpene류 물질이 들어있다. 지유(오이풀의 뿌리)는 한방에서는 몸의 열을 내려주고 출혈을 그치게 하는 효능이 있고, 해독작용이 있는 것으로 알려져 있다. 지유(오이풀의 뿌리)같은 경우 화상치료, 지혈작용, 구토억제 작용, 항균 작용 등에 효과가 있다. Cucumber is a perennial plant belonging to the family Rosaceae. It is distributed in Korea, Japan, Europe, and Manchuria. When the leaves are picked and poured, they smell like cucumber and are called cucumber grass. In oriental medicine, the root of cucumber grass is used as a medicine called Jiyu. Cucumber root contains 17% tannin, 2.5% saponin, and glycosides called Sanguisorbigenin, and stems and leaves contain triterpene-like substances such as qurcetin, Kaemferol glycosides, and Ursolic acid. Jiyu (root of cucumber grass) is known to have the effect of lowering body heat and stopping bleeding in oriental medicine, and has a detoxifying effect. Oil (root of cucumber) is effective for burn treatment, hemostasis, vomiting suppression, and antibacterial action.

본 발명의 화장료 조성물은 특히 제한되는 것은 아니나, 피부 외용으로 사용하거나, 경구 섭취할 수 있다. 본 발명의 화장료 조성물은 지유 추출물을 유효성분으로 함유하며 피부학적으로 허용 가능한 부형제와 함께 기초 화장품 조성물(화장수, 크림, 에센스, 클렌징 폼 및 클렌징 워터와 같은 세안제, 팩, 보디오일), 색조 화장품 조성물(화운데이션, 립스틱, 마스카라, 메이크업 베이스), 두발 제품 조성물(샴푸, 린스, 헤어컨디셔너, 헤어젤) 및 비누 등의 형태로 제조될 수 있다.The cosmetic composition of the present invention is not particularly limited, but may be used for external application to the skin or may be taken orally. The cosmetic composition of the present invention contains a base oil extract as an active ingredient and is a basic cosmetic composition (face wash, cream, essence, cleansing foam and cleansing water-like cleansing agent, pack, bodioyl), and color cosmetic composition (Foundation, lipstick, mascara, makeup base), hair product composition (shampoo, conditioner, hair conditioner, hair gel) and soap.

상기 부형제로는 이에 한정되지는 않으나 예를 들어, 피부연화제, 피부 침투 증강제, 착색제, 방향제, 유화제, 농화제 및 용매를 포함할 수 있다. 또한, 향료, 색소, 살균제, 산화방지제, 방부제 및 보습제 등을 추가로 포함할 수 있으며, 물성개선을 목적으로 점증제, 무기염류, 합성 고분자 물질 등을 포함할 수 있다. 예를 들면, 본 발명의 화장료 조성물로 세안제 및 비누를 제조하는 경우에는 통상의 세안제 및 비누 베이스에 상기 지유 추출물을 첨가하여 용이하게 제조할 수 있다. 크림을 제조하는 경우에는 일반적인 수중유적형(O/W)의 크림베이스에 지유 추출물 또는 이의 염을 첨가하여 제조할 수 있다. 여기에 향료, 킬레이트제, 색소, 산화방지제, 방부제 등과 물성개선을 목적으로 한 단백질, 미네랄, 비타민 등 합성 또는 천연소재를 추가로 첨가할 수 있다.The excipients include, but are not limited to, for example, skin emollients, skin penetration enhancers, colorants, fragrances, emulsifiers, thickening agents and solvents. In addition, fragrances, pigments, disinfectants, antioxidants, preservatives and moisturizers may be further included, and for the purpose of improving physical properties, may include thickeners, inorganic salts, synthetic polymer materials, and the like. For example, in the case of preparing the cleanser and soap with the cosmetic composition of the present invention, it can be easily prepared by adding the above oil extract to a conventional cleanser and soap base. In the case of manufacturing the cream, it can be prepared by adding an oil-based extract or a salt thereof to a cream base of a general oil-in-water type (O/W). Synthetic or natural materials such as proteins, minerals, vitamins, etc. for the purpose of improving physical properties may be additionally added to fragrances, chelating agents, pigments, antioxidants, preservatives, and the like.

본 발명의 화장료 조성물에 함유되는 지유 추출물의 함량은 이에 한정되지 않지만 전체 조성물 총중량에 대하여 0.001 내지 10 중량%인 것이 바람직하고, 0.01 내지 5중량%인 것이 더욱 바람직하다. 상기 함량이 0.001중량% 미만에서는 목적하는 피부 미백 또는 색소 침착 개선 효과를 기대할 수 없고, 10중량% 초과에서는 안전성 또는 제형상의 제조에 어려움이 있을 수 있다.The content of the oil extract contained in the cosmetic composition of the present invention is not limited to this, but is preferably 0.001 to 10% by weight, more preferably 0.01 to 5% by weight relative to the total weight of the total composition. If the content is less than 0.001% by weight, the desired effect of improving skin whitening or pigmentation cannot be expected, and if it is more than 10% by weight, there may be difficulties in safety or formulation.

상기 오이풀의 열수추출물은 40℃ 내지 160℃에서 1시간 내지 5시간 추출할 수 있으며, 바람직하게는 60℃ 내지 120℃에서 1시간 내지 3시간 추출할 수 있으며, 가장 바람직하게는 80℃ 내지 120℃에서 2시간 동안 추출할 수 있다. The hot water extract of the cucumber pool can be extracted from 40°C to 160°C for 1 hour to 5 hours, preferably from 60°C to 120°C for 1 hour to 3 hours, most preferably from 80°C to 120°C Can be extracted for 2 hours.

본 발명에 있어서, 상기 화장료 조성물은 여드름균인 프로피오니박테리움 애크니스(Propionibacterium acnes)의 활성을 억제하는 것을 특징으로 할 수 있다. In the present invention, the cosmetic composition may be characterized by inhibiting the activity of the acne bacteria Propionibacterium acnes (Propionibacterium acnes).

본 발명에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 열수추출물은 오이풀의 꽃, 잎, 줄기, 열매, 종자, 뿌리 및 전초를 포함하는 군으로부터 선택된 1 종 이상의 열수추출물인 것을 특징으로 할수 있고, 바람직하게는 오이풀의 뿌리 일 수 있다. In the present invention, the hot water extract of the cucumber (Sanguisorba officinalis) may be characterized in that it is one or more hot water extracts selected from the group comprising flowers, leaves, stems, fruits, seeds, roots and outposts of the cucumber grass, preferably Can be the root of cucumber grass.

본 발명에 있어서, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 함유 클렌징, 오일, 분말파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 및 스프레이를 포함하는 군으로부터 선택된 1종 이상의 제형을 갖는 것을 특징으로 할 수 있으며, 바람직하게는 비누 또는 계면 활성제 함유 클렌징일 수 있다. In the present invention, the cosmetic composition comprises a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, and spray It may be characterized by having one or more formulations selected from the group, preferably soap or surfactant-containing cleansing.

본 발명에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 열수추출물은 350 ㎍/mL 내지 850 ㎍/mL 농도로 포함되는 것을 특징으로 할 수 있고, 바람직하게는 625㎍/mL일 수 있다. In the present invention, the hot water extract of the cucumber (Sanguisorba officinalis) may be characterized in that it is included in a concentration of 350 ㎍ / mL to 850 ㎍ / mL, preferably 625㎍ / mL.

본 발명에 있어서, 상기 분획물은 오이풀 (Sanguisorba officinalis)의 열수추출물부터 에틸아세테이트로 분획하여 획득한 에틸아세테이트 분획물을 포함하는 것을 특징으로 할 수 있다. In the present invention, the fraction may be characterized in that it comprises an ethyl acetate fraction obtained by fractionation with ethyl acetate from a hot water extract of cucumber (Sanguisorba officinalis).

본 발명에 있어서, 상기 에틸아세테이트 분획물는 하이드록시시나믹 산(hydroxycinnamic acids) 및 플라보놀 (flavonols)으로 이루어진 군으로부터 선택되는 어느 하나 이상의 유효성분을 포함하는 것을 특징으로 할 수 있다. In the present invention, the ethyl acetate fraction may be characterized in that it contains any one or more active ingredients selected from the group consisting of hydroxycinnamic acids and flavonols.

본 발명에 있어서, 에틸아세테이트 분획물은 100 ㎍/mL 내지 200 ㎍/mL 농도로 포함하는 것을 특징으로 할 수 있으며, 바람직하게는 156 ㎍/mL으로 할 수 있다. In the present invention, the ethyl acetate fraction may be characterized as comprising 100 μg/mL to 200 μg/mL concentration, preferably 156 μg/mL.

오이풀 (Sanguisorba officinalis)의 열수추출물 또는 이의 분획물을 포함하는 의약외품을 제공할 수도 있다. It is also possible to provide quasi-drugs containing a hot water extract of Sanguisorba officinalis or a fraction thereof.

본 발명의 조성물을 의약외품 첨가물로 사용할 경우, 상기 추출물 또는 분획물을 그대로 첨가하거나 다른 의약외품 또는 의약외품 성분과 함께 사용할 수 있고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 유효성분의 혼합량은 사용 목적에 따라 적합하게 결정될 수 있다.본 발명의 의약외품 조성물은 이에 제한되지는 않으나, 바람직하게는 소독청결제, 샤워폼, 가그린, 물티슈, 세제비누, 핸드워시, 마스크, 연고제, 패치, 또는 필터 충진제일 수 있다.When the composition of the present invention is used as a quasi-drug additive, the extract or fraction may be added as it is or used with other quasi-drugs or quasi-drug components, and may be suitably used according to a conventional method. The mixing amount of the active ingredient may be appropriately determined according to the purpose of use. The quasi-drug composition of the present invention is not limited thereto, but preferably, disinfecting cleaners, shower foams, greens, wipes, detergent soaps, hand washes, masks, ointments, It can be a patch, or a filter filler.

이하, 실시예에 따라서 본 발명을 보다 구체적으로 설명하지만, 본 발명이 이하의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail according to examples, but the present invention is not limited by the following examples.

지유의 열수추출물 및 분획물Hot water extract and fractions of oil

1. 지유의 열수추출물(HWE) 제조1. Manufacture of hot water extract (HWE) of oil

오이풀 뿌리(지유)를 증류수로 세척하고 건조시킨 후 분쇄기로 잘게 분쇄하였다. 분쇄물 시료(50g)를 10배 중량의 100℃의 물을 가하고 2시간 동안 추출한 후 와트만 종이 여과지(Whatman No. 2)로 여과한 후 그 여액을 65±2℃ 감압 농축하고 초저온냉동고에서 동결한 후 냉동건조기(freeze dryer)로 동결 건조하여 최종 추출물 0.4673g을 수득하였다. 지유 건물로부터 열수 추출을 통한 수확량은 하기 표 1과 같다. Cucumber roots (oil) were washed with distilled water, dried and then finely crushed with a grinder. The pulverized sample (50 g) was added with 10-fold weight of 100° C., extracted for 2 hours, filtered with Whatman No. 2, and the filtrate was concentrated under reduced pressure at 65±2° C. and frozen in a cryogenic freezer. Then, freeze-drying with a freeze dryer gave 0.4673 g of the final extract. Table 1 shows the yield of hot water extracted from the base oil building.

지유로부터 열수 추출을 통한 수확량 Yield through extraction of hot water from oil 지유 건물중Jiyu building 열수추출물(HWE)의 동결건조 수확량Freeze-dried yield of hot water extract (HWE) 50 g50 g 0.4673g0.4673 g

2. 열수추출물의 분획물(HWE fraction) 제조 2. Preparation of HWE fraction

열수추출물에 일정량의 물을 첨가한 후, 분액여두를 이용하여 극성이 다른 추출용매인 n-헥산, 에틸아세테이트, 부탄올 및 물을 차례대로 혼합하여 각 분획을 추출하였다. 먼저 분액여두에 n-헥산을 증류수와 동량으로 넣고, 잘 혼합한 후 수층과 추출용매의 두 층으로 나뉘도록 방치하였다. 추출용매를 분리하고 남은 여액을 다시 같은 방법으로 에틸아세테이트와 부탄올을 차례대로 넣어 각각 추출하였다. 이때 추출용매는 남은 여액과 같은 양으로 첨가하였다. 추출 및 분획 공정의 개략도를 [도 1]에 나타내었다. 실험결과, 순차적 분획물은 지유의 열수추출물 50 g을 증류수 500 mL에 현탁시킨 후에 n-헥산(500 mL), 에틸아세테이트 (500 mL), n-부탄올 (500 mL) 그리고 증류수로 순차적으로 분획하여 분획물을 얻었다. After adding a certain amount of water to the hot water extract, each fraction was extracted by sequentially mixing n-hexane, ethyl acetate, butanol, and water, which are different polarity extraction solvents, using a separating filter. First, n-hexane was added to distilled water in the same amount as distilled water, mixed well, and left to be divided into two layers, an aqueous layer and an extraction solvent. The extraction solvent was separated, and the remaining filtrate was extracted with ethyl acetate and butanol in turn in the same manner. At this time, the extraction solvent was added in the same amount as the remaining filtrate. The schematic diagram of the extraction and fractionation process is shown in [Figure 1]. As a result of the experiment, the sequential fraction was suspended by distilling 50 g of hot water extract of fat oil into 500 mL of distilled water, and then sequentially fractionating it with n-hexane (500 mL), ethyl acetate (500 mL), n-butanol (500 mL) and distilled water. Got

식물 추출물 및 분획물의 항균 활성 실험Antibacterial activity test of plant extracts and fractions

그람음성균(2종) 및 그람양성균(3종)에 대한 항균 활성 측정은 원판 확산법(paper disk diffusion method), 최소억제농도(minimum inhibitoryconcentration, MIC) 및 최소살균농도(minimum bactericidal concentration, MBC)를 사용하여 평가하였다.To measure the antimicrobial activity against Gram-negative bacteria (2 species) and Gram-positive bacteria (3 species), the paper disk diffusion method, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were used. Was evaluated.

1. 대상 균주 및 배양조건1. Target strain and culture conditions

본 발명에 사용된 그람양성균인 프로피오니박테리움 애크니스 (KCTC3314; 생물자원센터)는 brain-heart infusion(BHI) 배지에서 혐기적 조건으로 2일 이상 배양하였으며, 리스테리아 모노사이토젠스(Listeria monocytogenes)와 포도상구균(Staphylococccus aureus)은 BHI 배지에서 호기적 조건으로 액체 배양하였다. 본 발명에 사용된 그람음성균인 대장균(Escherichia coli)과 비브리오장염균(Vibrio parahaemolyticus)는 Luria-Bertani(LB) 배지에서 액체배양하였다. 접종된 각 균주는 37℃, 200 rpm 조건에서 1~2일간 vernight) 진탕배양한 후 각 균의 성장과 용균은 Biochrom Libra S22 분광광도계(spectrophotometer)를 이용하여 O.D. 600nm에서 측정하였다.The Gram-positive bacteria used in the present invention, Propionibacterium acne (KCTC3314; Biological Resource Center) was cultured for more than 2 days in anaerobic conditions in brain-heart infusion (BHI) medium, Listeria monocytogenes and Staphylococccus aureus was cultured in BHI medium under aerobic conditions. The Gram-negative bacteria Escherichia coli and Vibrio parahaemolyticus used in the present invention were cultured in liquid in Luria-Bertani (LB) medium. Each inoculated strain is shaken and cultured for 1~2 days at 37°C and 200 rpm for shaking, and the growth and lysis of each bacterium is measured using a Biochrom Libra S22 spectrophotometer. Measured at 600 nm.

2. 원판 평판배지 확산법(paper disc agar diffusion method)2. Paper disc agar diffusion method

배양한 균주를 일정한 농도(optical density 600 nm에서 흡광값 0.5)로 조절한 것을 멸균된 면봉을 이용하여 BHI 한천플레이트(agar plate) 혹은 LB 한천플레이트에 균일하게 도말하였다. 플레이트를 건조시킨 후, paper disc(Φ 6 mm, Adventec. USA)를 균주를 접종한 플레이트 표면위에 올려놓고 열수 추출물액 각각을 1, 3, 5 혹은 10 mg/disk씩 흡수시켰다. 시료가 처리된 플레이트를 48 시간 동안 37℃ 조건에서 배양한 후 디스크 주위의 생육 억제환(inhibition zone)의 크기로 항균 활성을 측정하였다. 이때 대조군으로는 항생제인 4종(ampicillin, kanamycin, spectinomycin, timentin)을 사용하였고, 처리 농도는 20 ug/disc이다. 실험결과, 지유의 열수추출물물 10 mg/disk 처리구에서 강력한 항여드름균 활성이 확인되었다 [도 2A 및 표 2]. 농도별 처리구에서도 1 mg/disk 처리구까지 우수한 항여드름균 활성이 확인되었다 [도 2B]. 그러나 다른 4종 박테리아에 대해서는 항균 활성이 전혀 관찰되지 않았다. 이 결과를 통해 지유의 열수추출물은 프로피오니박테리움 애크니스에 대해 특이적 항균활성을 가지는 것으로 나타났으나, 다른 박테리아에 대해서는 항균활성이 없는 것으로 나타났다.The cultured strain was uniformly plated on a BHI agar plate or an LB agar plate using a sterile cotton swab that was adjusted to a constant concentration (absorption value 0.5 at an optical density of 600 nm). After drying the plate, a paper disc (Φ 6 mm, Adventec. USA) was placed on the surface of the plate inoculated with the strain, and each of the hot water extracts was absorbed by 1, 3, 5 or 10 mg/disk. After the sample-treated plate was incubated at 37°C for 48 hours, the antibacterial activity was measured by the size of the inhibition zone around the disc. At this time, four antibiotics (ampicillin, kanamycin, spectinomycin, timentin) were used as controls, and the treatment concentration was 20 ug/disc. As a result of the experiment, strong anti-acne activity was confirmed in the hot water extract 10mg/disk treatment of fat milk [Fig. 2A and Table 2]. Excellent anti-acne activity was also confirmed up to 1 mg/disk treatment in each treatment group by concentration [Fig. 2B]. However, no antibacterial activity was observed for the other 4 bacteria. Through these results, the hot water extract of the oil was found to have specific antibacterial activity against propionium bacterium acne, but no antibacterial activity against other bacteria.

그람양성균 프로피오니박테리움 애크니스에 대한 항균 활성Antibacterial activity against Gram-positive bacteria Propionibacterium acne 시료(10 mg/disc)Sample (10 mg/disc) 생육억제환 크기(cm)Growth inhibition ring size (cm) 열수추출물(HWE)Hot Water Extract (HWE) 3.4 x 3.53.4 x 3.5 ampicillinampicillin kanamycinkanamycin 3.1 x 3.03.1 x 3.0 spectinomycinspectinomycin timentintimentin

또한, 지유의 열수추출물로부터 획득한 에틸아세이트 분획물에서 우수한 항여드름균 활성이 관찰되었으나, 헥산, 부탄올 및 증류수 분획물에서는 미약하거나 관찰되지 않았다 [도 3]. 에틸아세이트 분획물의 농도별 처리 결과 1 mg/disk 처리구까지 우수한 항여드름균 활성이 확인되었다 [도 2C]. In addition, excellent anti-acne activity was observed in the ethyl acetate fraction obtained from the hot water extract of fat oil, but was weak or not observed in the hexane, butanol and distilled water fractions [FIG. 3 ]. As a result of treatment by concentration of ethyl acetate fraction, excellent anti-acne activity was confirmed up to 1 mg/disk treatment [Figure 2C].

3. 여드름균에 대한 지유 열수추출물(HWE) 및 에틸아세트 분획물(HWE-EA)의 최소억제농도(MIC) 및 최소살균농도(MBC)3. Minimum inhibitory concentration (MIC) and minimum sterilization concentration (MBC) of oil-based hot water extract (HWE) and ethylacetate fraction (HWE-EA) for acne bacteria

프로피오니박테리움 애크니스를 BHI broth 배지를 함유한 시험관에서 24 시간 동안 37℃ 조건에서 배양하였다. 여기에 열수추출물 및 에틸아세트 분획물을 2배 연속 희석법(two-fold dilution)으로 희석하여 시험관에 첨가하였다. 균희석액 및 시료를 접종한 시험관에서 48 시간 배양한 후 균의 가시적 생장을 저해하는 최소 농도를 MIC로 결정하였다. 하기 [표 3]에 나타낸 바와 같이, 프로피오니박테리움 애크니스에 대한 열수추출물 및 에틸아세테이트 분획물의 MIC 값은 625 μg/mL 및 156 μg/mL로 측정되었다. MIC로 선택된 농도보다 그 이상의 농도에 해당하는 시험관의 배양액 100 μL 씩 고체배지에 도말하여 균을 배양한 후 plate 상에서 관찰되는 콜로니(colony) 수를 직접 계수하였다. 이때 확인되어지는 콜로니 수가 100% 사멸되어지는 효과를 나타내는 추출물 처리농도를 MBC로 결정하고 하기 [표 3] 및 [도 4]와 같이 결정하였다. 하기 [표 3]에 나타낸 바와 같이, 프로피오니박테리움 애크니스에 대한 열수추출물 및 에틸아세테이트 분획물의 MBC 값은 1250 μg/mL 및 312 μg/mL로 측정되었다.Propionibacterium acne was incubated at 37° C. for 24 hours in a test tube containing BHI broth medium. Here, the hot water extract and ethylacetate fraction were diluted in a two-fold dilution method and added to a test tube. After culturing for 48 hours in a test tube inoculated with the bacterial dilution solution and the sample, the minimum concentration that inhibited the visible growth of the bacteria was determined as the MIC. As shown in Table 3 below, the MIC values of the hot water extract and ethyl acetate fraction for Propionibacterium acne were measured to be 625 μg/mL and 156 μg/mL. 100 microliters of the culture medium of the test tube corresponding to a concentration higher than the concentration selected by the MIC was smeared on a solid medium, and the bacteria were cultured, and the number of colonies observed on the plate was directly counted. At this time, the concentration of the extract showing the effect of killing 100% of the number of colonies confirmed was determined by MBC and determined as shown in Tables 3 and 4 below. As shown in Table 3 below, the MBC values of the hot water extract and ethyl acetate fraction for Propionibacterium acne were measured to be 1250 μg/mL and 312 μg/mL.

지유 열수추출물과 추출물의 에틸아세테이트 분획물의 프로피오니박테리움 애크니스에 대한 최소억제농도 및 최소살균농도Minimum inhibitory and minimum sterilization concentrations for propionibacterium acnes of ethyl acetate fractions of oil-based hot water extracts and extracts 추출물extract MIC(㎍/mL)MIC (µg/mL) MBC(㎍/mL)MBC (µg/mL) 열수추출물(HWE)Hot Water Extract (HWE) 625625 12501250 에틸아세테이트 분획물(HWE-EA)Ethyl acetate fraction (HWE-EA) 156156 312312

항여드름균 활성을 가진 에틸아세티이트 분획물의 성분 분석 Component analysis of ethyl acetate fraction with anti-acne activity

1. 박층 크로마토그래피(Thin layer chromatography; TLC)1.Thin layer chromatography (TLC)

항여드름균 활성을 가진 에틸아세티이트 분획물을 silica gel 60 glass plate(20 x 20 cm, Merck, DarDarmstadt, Germany)를 이용하여 에틸아세테이트/헥산/클로로포름/ 초산(40:30:30:2, v/v/v/v) 혼합 용매로 하여 전개하고 UV 램프(254 nm 및 366 nm 파장) 및 황산 스프레이 발색법으로 에틸아세테이드 분획물과 표준물질(caffeic acid, ferulic acid, quercetin, kaempferol)과의 Rf 값을 비교하여 분석하였다. 상기의 방법으로 실험한 결과 표준물질인 caffeic acid, ferulic acid, quercetin, kaempferol Rf 값과 비슷한 band를 확인할 수 있었다 [도 5.]The ethyl acetate fraction having anti-acne activity was silica gel 60 glass plate (20 x 20 cm, Merck, DarDarmstadt, Germany) using ethyl acetate/hexane/chloroform/acetic acid (40:30:30:2, v /v/v/v) developed as a mixed solvent and combined with ethyl acetate fraction and standard materials (caffeic acid, ferulic acid, quercetin, kaempferol) by UV lamp (254 nm and 366 nm wavelength) and sulfuric acid spray coloration method. Rf values were compared and analyzed. As a result of experimenting with the above method, a band similar to the standard substances caffeic acid, ferulic acid, quercetin, and kaempferol Rf was confirmed.

2. High performance liquid chromatography(HPLC)2. High performance liquid chromatography (HPLC)

에틸아세테이트 분획물을 methanol에 녹이고 여과(0.45 μm filter)하여 HPLC(1260 Infinity Quaternary LCSystem, Agilent Technologies, Waldbronn, Germany)에 ZORBAX Eclipse Plus C18 column(4.6×150 mm, 5 μm, Agilent Technologies, Lawrence, KS, USA)을 사용하여 254 nm에서 분석하였다. Injection volume은 10 μL, 이동상은 용매 A(2% acetic acid in 30% methanol)와 B(2% acetic acid in 50% acetonitrile)를 유속 1mL/min으로 A액과 B액의 비율 100:0(v/v)에서 70분까지 0:100(v/v)의 비율로 농도기울기법으로 분석하였다. 함량 측정은 표품 caffeic acid, ferulic acid, quercetin, kaempferol을 이용하여 작성한 검량선의 회귀식에서 구하였다. 상기의 방법으로 실험한 결과 역상 HPLC 방법으로 청미래의 분획물 중에서 표준물질과의 retention time을 비교하여 2종의 hydroxycinnamic acids(caffeic acid, ferulic acid) 및 2종의 flavonols(quercetin, kaempferol)을 확인하였다 [도 6]. 지유 열수추출물의 에틸아세테이트 분획물 중 caffeic acid, ferulic acid, quercetin, kaempferol 등을 포함하여 여러 미지 물질이 검출되었으며 그중 ferulic acid 함량이 가장 높았다. The ethyl acetate fraction was dissolved in methanol and filtered (0.45 μm filter) to ZORBAX Eclipse Plus C18 column (4.6×150 mm, 5 μm, Agilent Technologies, Lawrence, KS, HPLC) on HPLC (1260 Infinity Quaternary LCSystem, Agilent Technologies, Waldbronn, Germany). USA). Injection volume is 10 μL, mobile phase is solvent A (2% acetic acid in 30% methanol) and B (2% acetic acid in 50% acetonitrile) at a flow rate of 1 mL/min. /v) from 70 to 70 minutes at a ratio of 0:100 (v/v). The content measurement was obtained from the regression equation of the calibration curve prepared using the samples caffeic acid, ferulic acid, quercetin, and kaempferol. As a result of experimenting with the above method, the retention time with the standard substance was compared in the fractions of blue and white by reverse-phase HPLC method to confirm two hydroxycinnamic acids (caffeic acid, ferulic acid) and two flavonols (quercetin, kaempferol) [ Fig. 6]. Among the ethyl acetate fractions of the oil-based hot water extract, several unknown substances were detected, including caffeic acid, ferulic acid, quercetin, and kaempferol, among which the highest ferulic acid content was detected.

Claims (9)

오이풀 (Sanguisorba officinalis)의 열수추출물 또는 이의 분획물을 포함하고,
상기 오이풀 (Sanguisorba officinalis)의 열수추출물은 350 ㎍/mL 내지 625 ㎍/mL 농도로 포함되는 것을 특징으로 하며,
상기 분획물은 오이풀 (Sanguisorba officinalis)의 열수추출물부터 에틸아세테이트로 분획하여 획득한 에틸아세테이트 분획물인 것을 특징으로 하고,
상기 에틸아세테이트 분획물은 100 ㎍/mL 내지 200 ㎍/mL 농도로 포함하는 것을 특징으로 하는,
여드름균인 프로피오니박테리움 애크니스(Propionibacterium acnes)의 활성를 억제하는, 여드름 개선용 화장료 조성물.
Cucumber (Sanguisorba officinalis) contains a hot water extract or a fraction thereof,
The hot water extract of the cucumber (Sanguisorba officinalis) is characterized in that it is included in a concentration of 350 ㎍ / mL to 625 ㎍ / mL,
The fraction is characterized in that it is an ethyl acetate fraction obtained by fractionation with ethyl acetate from a hot water extract of cucumber (Sanguisorba officinalis),
The ethyl acetate fraction is characterized in that it comprises a concentration of 100 ㎍ / mL to 200 ㎍ / mL,
A cosmetic composition for improving acne, which suppresses the activity of the acne bacterium Propionibacterium acnes.
삭제delete 제 1항에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 열수추출물은 오이풀의 꽃, 잎, 줄기, 열매, 종자, 뿌리 및 전초를 포함하는 군으로부터 선택된 1 종 이상의 열수추출물인 것을 특징으로 하는 여드름 개선용 화장료 조성물. The method according to claim 1, wherein the hot water extract of the cucumber (Sanguisorba officinalis) is one or more hot water extracts selected from the group comprising flowers, leaves, stems, fruits, seeds, roots and outposts of the cucumber grass for acne improvement. Cosmetic composition. 제 1 항에 있어서, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 함유 클렌징, 오일, 분말파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 및 스프레이를 포함하는 군으로부터 선택된 1종 이상의 제형을 갖는 것을 특징으로 하는 여드름 개선용 화장료 조성물. The method of claim 1, wherein the cosmetic composition is a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, and spray A cosmetic composition for improving acne, characterized by having at least one formulation selected from the group. 삭제delete 삭제delete 제 1항에 있어서, 상기 에틸아세테이트 분획물는 하이드록시시나믹산(hydroxycinnamic acids) 및 플라보놀 (flavonols)으로 이루어진 군으로부터 선택되는 어느 하나 이상의 유효성분을 포함하는 것을 특징으로 하는, 여드름 개선용 화장료 조성물.The cosmetic composition for improving acne according to claim 1, wherein the ethyl acetate fraction contains at least one active ingredient selected from the group consisting of hydroxycinnamic acids and flavonols. 삭제delete 오이풀 (Sanguisorba officinalis)의 열수추출물 또는 이의 분획물을 포함하고,
상기 오이풀 (Sanguisorba officinalis)의 열수추출물은 350 ㎍/mL 내지 625 ㎍/mL 농도로 포함되는 것을 특징으로 하며,
상기 분획물은 오이풀 (Sanguisorba officinalis)의 열수추출물부터 에틸아세테이트로 분획하여 획득한 에틸아세테이트 분획물인 것을 특징으로 하고,
상기 에틸아세테이트 분획물은 100 ㎍/mL 내지 200 ㎍/mL 농도로 포함하는 것을 특징으로 하는, 여드름균인 프로피오니박테리움 애크니스(Propionibacterium acnes)의 활성를 억제하는 의약외품.
Cucumber (Sanguisorba officinalis) contains a hot water extract or a fraction thereof,
The hot water extract of the cucumber (Sanguisorba officinalis) is characterized in that it is included in a concentration of 350 ㎍ / mL to 625 ㎍ / mL,
The fraction is characterized in that it is an ethyl acetate fraction obtained by fractionation with ethyl acetate from a hot water extract of cucumber (Sanguisorba officinalis),
The ethyl acetate fraction is characterized in that it comprises a concentration of 100 ㎍ / mL to 200 ㎍ / mL, quasi-drug to inhibit the activity of acne bacteria Propionibacterium acnes (Propionibacterium acnes).
KR1020170083419A 2017-06-30 2017-06-30 A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium Active KR102132514B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170083419A KR102132514B1 (en) 2017-06-30 2017-06-30 A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170083419A KR102132514B1 (en) 2017-06-30 2017-06-30 A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium

Publications (2)

Publication Number Publication Date
KR20190003009A KR20190003009A (en) 2019-01-09
KR102132514B1 true KR102132514B1 (en) 2020-08-05

Family

ID=65017391

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170083419A Active KR102132514B1 (en) 2017-06-30 2017-06-30 A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium

Country Status (1)

Country Link
KR (1) KR102132514B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103372076A (en) * 2012-04-20 2013-10-30 北京北大维信生物科技有限公司 Medicine for treating diseases caused by propionibacterium acnes and application of sanguisorba officinalis and/or sanguisorba officinalis extract

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100610951B1 (en) 1998-09-17 2007-04-25 애경산업(주) Composition for Skin-antiacne
KR100407128B1 (en) 2000-10-20 2003-11-28 주식회사 바이오리 Skin external preparation containing pine pollen or pine pollen extract
KR20020073041A (en) * 2001-03-14 2002-09-19 주식회사 에스티씨나라 Composition of natural material for acne treatment and prevention
KR100441131B1 (en) 2001-08-22 2004-07-21 애경산업(주) Cosmetic compositons for acne skin containing natural fragrant oil
KR100663981B1 (en) 2003-03-13 2007-01-03 한국콜마 주식회사 Cosmetic composition effective for acne containing citrus essential oil
KR100700911B1 (en) 2005-12-30 2007-03-28 고려대학교 산학협력단 Acidic polysaccharide extracted from ginseng root and its composition for preventing human cellular interaction of Propionibacterium acnes and Staphylococcus aureus
KR100700912B1 (en) 2005-12-30 2007-03-28 고려대학교 산학협력단 Human Cell Binding Inhibitory Activity of Acne Bacillus and Atopic Staphylococcus aureus Containing Acidic Polysaccharides Isolated from Green Tea Leaves
KR100791420B1 (en) 2006-05-15 2008-01-07 고려대학교 산학협력단 Composition for inhibiting human cell binding of skin acne bacilli and atopy Staphylococcus aureus containing acidic polysaccharides isolated from mugwort
KR100860272B1 (en) 2006-11-17 2008-09-25 주식회사 휴온스 Extraction and purification method of active ingredient from Seonhakcho, and herbal composition for preventing and treating acne containing the extract
KR101020536B1 (en) 2008-05-09 2011-03-09 (주)더페이스샵 Cosmetic composition for moisturizing skin containing cucumber extract and method for producing same
KR101326164B1 (en) 2011-01-25 2013-11-06 재단법인 제주테크노파크 External Composition for Skin Having Antibacterial Activities
KR20130113018A (en) 2012-04-05 2013-10-15 이진태 Development of a mouthwash using sanguisoba officinalis for breaking down plaque
KR101533624B1 (en) 2013-06-25 2015-07-07 한국콜마주식회사 A Cosmetic Composition Containing Extracts of Potentilla kleiniana Wight et Arnott Having antibacterial Activity
KR20140099223A (en) 2014-07-17 2014-08-11 (주)제주사랑농수산 Antimicrobial Composition Using an Plant Extract
KR101507889B1 (en) 2014-11-04 2015-04-07 한국콜마주식회사 COSMETIC COMPOSITION CONTAINING EXTRACT FROM Callistemon lanceola HAVING ANTI-ACNE MICROBE ACTIVITY
KR101737854B1 (en) 2015-02-23 2017-05-19 한림대학교 산학협력단 Composition for treating diabete and diabete-induced complication containing an extract from Sanguisorba officinalis L.
KR101732022B1 (en) 2015-06-18 2017-05-12 전남대학교산학협력단 Anti-Viral Compositions against Fish Pathogenic Virus comprising Extract or Fractions from Sanguisorba officinlis as Active Ingredient
KR101784254B1 (en) 2015-11-11 2017-10-11 전북대학교산학협력단 Composition for preventing or treating sepsis comprising Sanguisorba officinalis extract as effective component

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103372076A (en) * 2012-04-20 2013-10-30 北京北大维信生物科技有限公司 Medicine for treating diseases caused by propionibacterium acnes and application of sanguisorba officinalis and/or sanguisorba officinalis extract

Also Published As

Publication number Publication date
KR20190003009A (en) 2019-01-09

Similar Documents

Publication Publication Date Title
KR101870780B1 (en) A feminine cleanser composition comprising roes damascena flower oil and propolis complex extracts
KR20110108686A (en) Antioxidant comprising natural raw extract and feed, food or cosmetic composition comprising same
KR20110108687A (en) Whitening agent comprising natural raw extract and cosmetic composition comprising same
KR101868507B1 (en) Cosmetic Composition for Anti-oxidation, Anti-inflammatory and Anti-wrinkling Comprising Enzyme-treated Extracts of Annona Muricata and Method for Manufacturing the Same
KR102180666B1 (en) Cosmetic Composition for Skin Care Containing Fermented Extracts of Applemint, Citron and Sparassis Crispa
KR102065185B1 (en) Composition for Improving Skin Conditions with Improved Anti-Bacterial, Anti-inflammatory, Anti-wrinkling, and Skin Whitening Property
KR102594733B1 (en) Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof
KR102400179B1 (en) Cosmetic composition antimicroboal, antioxidation, whitening or anti-inflammation comprising artemisia capillaris thunberg and olive extract
KR102359223B1 (en) Cosmetic composition comprising mangifera indica irwin seed extract
KR20190049067A (en) A cosmetic composition comprising extract of coffee silver skin and coffee grounds
KR102059392B1 (en) Antimicrobial and Antifungal Composition Containing Clove, Hibiscus, and Coconut Extract Complex as Active Ingredient
KR20200036304A (en) Plant extract fermented with scoria and cosmetic composition containing the same
EP2512495B1 (en) Process for obtaining a standardised extract of quercetin an 3-o-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract
KR102133074B1 (en) A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium
KR20240004199A (en) Antibacterial composition containing extract or fractions of Prunus pendula for. ascendens
KR102132514B1 (en) A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium
KR102367027B1 (en) Antimicrobial composition comprising Hydrangea petiolaris extracts or fractions thereof as effective component
KR102214505B1 (en) Skin External Preparation and Cosmetic Compositions Comprising Extract of Viburnum erosum Thunb.
KR20190102364A (en) Anti-aging composition and cosmetic using the same
KR20230113453A (en) Composition for treating or preventing atopic dermatitis or acne comprising herbal extract with improved skin absorption and manufacturing method thereof
KR101598194B1 (en) Multifunctional deodorant cosmetic composition for hair and body
KR20230160232A (en) Extract of upper growth of holy basil, and cosmetic or dermatological composition containing same
KR100993676B1 (en) Composition for preventing or treating acne
KR102692062B1 (en) A cosmetic composition having anti-oxidant, anti-inflammatory, protection of skin cell induced by ultraviolet ray and skin whitening effects comrising camellia sinensis extract, rumex crispus extract and inula britannica extract
KR20210030753A (en) An anti-acne composition comprising dryopteris erythrosora extracts as an active ingredient

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20170630

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20181030

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20170630

Comment text: Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200121

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20200701

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20200703

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20200703

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20230516

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20240523

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20250526

Start annual number: 6

End annual number: 6